TY - JOUR
T1 - Measuring E-cigarette dependence
T2 - Initial guidance
AU - Bold, Krysten W.
AU - Sussman, Steve
AU - O'Malley, Stephanie S.
AU - Grana, Rachel
AU - Foulds, Jonathan
AU - Fishbein, Howard
AU - Krishnan-Sarin, Suchitra
N1 - Funding Information:
This work was supported in part by grants from the National Institute on Drug Abuse and the FDA Center for Tobacco Products (CTP) (under Award Numbers P50DA036151 (SK-S, SSO); P50DA036107 (JF); T32DA019426 (KWB)). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health or the Food and Drug Administration.
Funding Information:
The authors would like to acknowledge the external expert review panel for providing valuable feedback and guidance related to e-cigarette dependence dimensions. This work was supported in part by grants from the National Institute on Drug Abuse and the FDA Center for Tobacco Products (CTP) (under Award Numbers P50DA036151 (SK-S, SSO); P50DA036107 (JF); T32DA019426 (KWB)).
Funding Information:
J.F. has done paid consulting for pharmaceutical companies involved in producing smoking cessation medications including GSK, Pfizer, Novartis, J&J, and Cypress Bioscience, and has received a research grant and study drug from Pfizer. SSO reports the following activities related to alcohol research: Member of the American Society of Clinical Psychopharmacology workgroup, the Alcohol Clinical Trials Initiative, supported with funding from Amygdala, Eli Lilly, Ethypharma, Lundbeck, Pfizer, Otsuka, Arbor Pharmaceuticals, Indivior; donated study medications, Pfizer Pharmaceuticals, Astra Zeneca; DSMB member, Emmes Corporation; Consultant/Advisory Board Member, Opiant, Mitsubishi Tanabe, Alkermes, Amygdala. Other authors have no conflicts to declare.
Publisher Copyright:
© 2017 Elsevier Ltd
PY - 2018/4
Y1 - 2018/4
N2 - E-cigarette use rates are increasing among youth and adults, despite limited knowledge about the safety, risks, and potential for this product in substituting for or reducing other tobacco use. Understanding how to characterize and assess e-cigarette dependence will be important for evaluating the public health impact of e-cigarettes and considering prevention and intervention strategies. To provide an initial review of constructs to consider when assessing e-cigarette dependence, a content expert group within the Tobacco Center for Regulatory Science (TCORS) Measurement Workgroup engaged in a review of published manuscripts and 12 tobacco dependence measures, followed by review of suggested dependence domains by a 10-person external subject-matter expert panel. The final domains selected to be considered in the development of a measure of e-cigarette dependence included: 1) Quantity and frequency of use, 2) Tolerance, 3) Perceived benefits, 4) Withdrawal symptoms, 5) Craving/urge to use, 6) Use despite harm, 7) Impaired control, 8) Automaticity, 9) Preferred over competing rewards, and 10) Sensory dependence. Similarities and differences in potential features of e-cigarette dependence compared with dependence on other tobacco products is discussed. Future work will evaluate these dependence items and constructs in a sample of e-cigarette users with a goal of developing a valid, brief, standardized measure of e-cigarette dependence.
AB - E-cigarette use rates are increasing among youth and adults, despite limited knowledge about the safety, risks, and potential for this product in substituting for or reducing other tobacco use. Understanding how to characterize and assess e-cigarette dependence will be important for evaluating the public health impact of e-cigarettes and considering prevention and intervention strategies. To provide an initial review of constructs to consider when assessing e-cigarette dependence, a content expert group within the Tobacco Center for Regulatory Science (TCORS) Measurement Workgroup engaged in a review of published manuscripts and 12 tobacco dependence measures, followed by review of suggested dependence domains by a 10-person external subject-matter expert panel. The final domains selected to be considered in the development of a measure of e-cigarette dependence included: 1) Quantity and frequency of use, 2) Tolerance, 3) Perceived benefits, 4) Withdrawal symptoms, 5) Craving/urge to use, 6) Use despite harm, 7) Impaired control, 8) Automaticity, 9) Preferred over competing rewards, and 10) Sensory dependence. Similarities and differences in potential features of e-cigarette dependence compared with dependence on other tobacco products is discussed. Future work will evaluate these dependence items and constructs in a sample of e-cigarette users with a goal of developing a valid, brief, standardized measure of e-cigarette dependence.
UR - http://www.scopus.com/inward/record.url?scp=85034791887&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85034791887&partnerID=8YFLogxK
U2 - 10.1016/j.addbeh.2017.11.015
DO - 10.1016/j.addbeh.2017.11.015
M3 - Article
C2 - 29174664
AN - SCOPUS:85034791887
SN - 0306-4603
VL - 79
SP - 213
EP - 218
JO - Addictive Behaviors
JF - Addictive Behaviors
ER -